Managed Account Advisors’s Core Laboratories CLB Stock Holding History

Managed Account Advisors’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	$17.8M	Sell	155,811 -896	-0.6%	-$109K	0.01%	773
2015 Q1	$16.4M	Buy	156,707 +6,451	+4%	+$687K	0.01%	829
2014 Q4	$18.1M	Sell	150,256 -43,173	-22%	-$5.67M	0.02%	754
2014 Q3	$28.3M	Buy	193,429 +8,979	+5%	+$1.39M	0.03%	548
2014 Q2	$30.8M	Buy	184,450 +50,696	+38%	+$9.02M	0.04%	500
2014 Q1	$26.5M	Sell	133,754 -833	-0.6%	-$157K	0.03%	540
2013 Q4	$25.7M	Sell	134,587 -2,359	-2%	-$439K	0.03%	545
2013 Q3	$23.2M	Buy	136,946 +7,786	+6%	+$1.21M	0.03%	552
2013 Q2	$19.6M	Buy	+129,160	New	+$18.3M	0.03%	579

Other funds holding CLB

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Wedgewood Partners St Louis, Missouri $484M AUM 16.04% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

WHV Investments San Francisco, California $187M AUM 14.29% 1-Year Est. Return

Managed Account Advisors's CLB Position: Q2 2015 in Review

Managed Account Advisors reduced its Core Laboratories (CLB) stake by 0.57% in Q2 2015, selling an estimated $109K and leaving 155,811 shares worth $17.8M. The position accounts for 0.01% of the portfolio, ranked #773.

Managed Account Advisors first reported a position in CLB in Q2 2013 and has held it in 9 quarters since. The position peaked at $30.8M in Q2 2014. 357 funds tracked by Wall St. Rank hold CLB as of Q2 2015.

Managed Account Advisors held 155,811 shares of Core Laboratories worth $17.8M as of Q2 2015.
Managed Account Advisors sold 896 Core Laboratories shares in Q2 2015, an estimated $109K.
Core Laboratories made up 0.01% of Managed Account Advisors's portfolio in Q2 2015, its #773 holding.
Managed Account Advisors first reported a position in Core Laboratories in Q2 2013 and has held it in 9 quarters since.
Managed Account Advisors's Core Laboratories position peaked at $30.8M in Q2 2014.
357 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2015.

Based on Managed Account Advisors's 13F filing for Q2 2015, filed 14 Aug 2015.